Beam Therapeutics
BEAM
$22.32
Share price
4.40%
Change (1 day)
-27.32%
Change (1 year)
Beam Therapeutics (BEAM) - Cash on Hand
Cash on Hand as of December 2023 : $1.18 B
According to Beam Therapeutics
's latest financial reports the company has $1.18 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Beam Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.18 B | 10.36% |
| 2022-12-31 | $1.07 B | 11.65% |
| 2021-12-31 | $0.96 B | 222.24% |
| 2020-12-31 | $0.29 B | 226.27% |
| 2019-12-31 | $91.84 M | -37.28% |
| 2018-12-31 | $0.14 B | 7603.47% |
| 2017-12-31 | $1.9 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -82.50% | 🇺🇸 USA |